Mastercard and the Medical Tourism Association join forces to revolutionize cross-border healthcare payments →

One of the leading doctors in the world, Dr. Mandeep Singh, offers this treatment with exceptional expertise. If you're interested in getting a free quote, submit a request via this link. Take the first step towards a healthier future today!

Chorionic Villous Sampling (CVS) is an essential prenatal diagnostic procedure that enables early detection of chromosomal abnormalities and genetic disorders in the developing fetus. It offers crucial information that can guide expectant parents and healthcare providers in making informed decisions about pregnancy management. This article delves into the intricacies of CVS, explaining its purpose, procedure, benefits, risks, and what to expect during and after the test.

What is Chorionic Villous Sampling?

Chorionic Villous Sampling is a prenatal test performed between the 10th and 13th weeks of pregnancy. It involves collecting a small sample of chorionic villi from the placenta. These villi share the fetus's genetic makeup, making them valuable for detecting genetic abnormalities.

Why is CVS Performed?

CVS is primarily conducted to identify chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13, as well as other genetic disorders like cystic fibrosis and sickle cell anemia. It is often recommended for:

  • Women over 35, who have a higher risk of chromosomal abnormalities.
  • Couples with a family history of genetic disorders.
  • Pregnancies with abnormal ultrasound findings.
  • Parents who are known carriers of genetic conditions.

How is the CVS Procedure Performed?

There are two methods for performing CVS: Transcervical and Transabdominal.

  1. Transcervical CVS:
    • The procedure involves inserting a thin, flexible tube (catheter) through the cervix to reach the placenta.
    • Guided by ultrasound, the doctor gently removes a small sample of chorionic villi.
  2. Transabdominal CVS:
    • This method involves inserting a thin needle through the abdominal wall and uterus to reach the placenta.
    • Ultrasound guidance ensures accurate placement, and a sample of chorionic villi is taken.

Both methods typically take about 30 minutes, including preparation time, and the actual sampling takes only a few minutes. Local anesthesia may be used to minimize discomfort.

Preparation for CVS

Before undergoing CVS, patients may be advised to:

  • Avoid eating or drinking for a few hours before the procedure.
  • Inform their healthcare provider about any medications they are taking.
  • Arrange for someone to accompany them to and from the appointment.

Risks and Benefits of CVS

Benefits:

  • Early Diagnosis: CVS provides early information about the fetus's health, allowing for timely decision-making.
  • Accuracy: It offers high accuracy in detecting genetic and chromosomal conditions.
  • Peace of Mind: For many parents, early testing can provide reassurance or help them prepare for a child with special needs.

Risks:

  • Miscarriage: The risk of miscarriage after CVS is about 1 in 100, slightly higher than the risk associated with amniocentesis.
  • Infection: There's a minimal risk of infection due to the invasive nature of the procedure.
  • Rh Sensitization: If the mother is Rh-negative, she may need an injection of Rh immunoglobulin to prevent Rh sensitization.

What to Expect After the Procedure

After CVS, patients might experience mild cramping or spotting. It's advisable to rest for the remainder of the day and avoid strenuous activities for a few days. If there is heavy bleeding, severe cramping, fever, or leaking of amniotic fluid, immediate medical attention should be sought.

Interpreting CVS Results

CVS results are typically available within 7 to 10 days. The results can confirm whether the fetus has a chromosomal abnormality or genetic disorder. In some cases, further testing might be required to clarify ambiguous results.

Alternatives to CVS

While CVS is a valuable diagnostic tool, there are alternatives such as:

  • Amniocentesis: Performed later in pregnancy (usually between 15 and 20 weeks), amniocentesis involves sampling the amniotic fluid surrounding the fetus.
  • Non-Invasive Prenatal Testing (NIPT): A blood test that analyzes fetal DNA circulating in the mother's blood. It poses no risk to the fetus but is less comprehensive than CVS.

Chorionic Villous Sampling is a critical prenatal diagnostic procedure that offers early insights into the genetic health of a fetus. While it carries some risks, its benefits in providing crucial information to expectant parents and healthcare providers make it a valuable tool in prenatal care. By understanding the procedure, preparation, risks, and benefits, industry professionals can better support and educate patients considering this test.

Better by MTA

ENGLISH
×

Choose your language